BioSpace News Archive

Diamond Therapeutics Announces Health Canada Approval of Clinical Trial with Low-Dose Psilocybin

Diamond Therapeutics Inc. is pleased to announce that it has received a No Objection Letter from Health Canada, allowing Diamond to proceed with a human clinical trial to evaluate low doses of psilocybin in healthy volunteers.

August 17, 2021
·
4 min read
BioForest

Receptor Life Sciences Announces Publication of Proof-of-Principle Clinical Pharmacokinetics Study of RLS103 (Inhaled Dry Powder CBD)

Receptor Life Sciences (RLS), a pharmaceutical company developing innovative therapies to address central nervous system disorders, announced the publication of a manuscript in the Journal of Pharmaceutical Sciences.

August 17, 2021
·
2 min read
Business

n-Lorem Foundation Appoints Sarah Glass, Ph.D., as Chief Development Officer

n-Lorem Foundation today announced the appointment of Sarah Glass, Ph.D., as its first-ever Chief Development Officer.

August 17, 2021
·
3 min read
Drug Development

Istari Oncology Initiates Its Phase I/II Sub-Study Evaluating PVSRIPO in Patients with Head and Neck Cancer

Istari Oncology, Inc. today announced the company is proceeding with the expansion of its LUMINOS-103 trial, with a new sub-study evaluating PVSRIPO in adult patients with head and neck squamous cell carcinoma (HNSCC).

August 17, 2021
·
4 min read
Business

Nxt-ID, Inc. Announces Investor Call to Discuss the Financial Results for Second Quarter and Year to Date Results Ended June 30, 2021

Nxt-ID, Inc. (NASDAQ: NXTD) (the “Company” or “Nxt-ID”), a provider of technology products and services for healthcare applications, announces financial results for the three months and six months ended June 30, 2021.

August 17, 2021
·
6 min read
Pharm Country

Bearpac Medical Selected to Exhibit the Passio Pump Drainage System at Vizient Innovative Technology Exchange

Bearpac Medical, LLC has been selected to exhibit the Passio Pump Drainage System for the drainage of recurrent and symptomatic pleural effusions at the Vizient Innovative Technology Exchange.

August 17, 2021
·
2 min read
Business

ImmixBio Announces Dr. Galit Lahav of Harvard Medical School Joins Scientific Advisory Board

Immix Biopharma, Inc. today announced that Galit Lahav, PhD, Novartis Professor of Systems Biology and Department Chair, Systems Biology at Harvard Medical School has joined its Scientific Advisory Board.

August 17, 2021
·
3 min read
Business

ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments

Today, global professional services firm ZS announced an exclusive partnership with and supporting investment in Intelligencia, an artificial intelligence company pioneering the use of machine learning to assess, quantify and reduce the risk of clinical development and guide pipeline decision-making.

August 17, 2021
·
4 min read
Biotech Bay

Vivalink Announces Real-World Evidence Data Platform to Power Virtual Patient Care and Decentralized Clinical Trials

Vivalink, a leading provider of digital healthcare solutions for real-world evidence data, announces today the launch of its enhanced Biometrics Data Platform to accelerate the development and deployment of patient monitoring and data analysis applications for ambulatory and remote settings.

August 17, 2021
·
3 min read
Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDA

Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today that it has filed a supplement to the COSIRA-II Investigational Device Exemption (IDE) Study with the U.S. Food and Drug Administration (FDA).

August 17, 2021
·
9 min read